Today's Earnings Calculators Terms of Service Privacy Policy Data Sources Support Mobile app Instagram

StockRay is an AI stock analysis service by Warm Tech Company.

Warm Tech Company | CEO Jinyoung Moon | Reg. 317-27-02126

13, Cheonggyesan-ro 4-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea | partner@warmtech.company

All information provided by Warm Tech Company is for reference only and does not constitute a recommendation to buy or sell any specific stock. You are solely responsible for your investment decisions.

© 2026 Warm Tech Company. All rights reserved.

Addex Therapeutics Ltd Stock Price·Forecast · AI Analysis | StockRay

Addex Therapeutics Ltd

ADXN · Healthcare · $3M

After-hours $2.73-7.46%

Jun 2026 reflected

Price

$5.72

$2.95

Jul 1, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

6/'26

Revenue$0M+20.4%

Operating Income-$1M-32.3%

Net Income-$2M-0.4%

3/'26 vs prev quarter

Company Health

Market Cap$3M

Operating Margin-4122.2%

Among 326 Biotechnology peers

LowMedianHigh

PSR42.8x

median 11.1x

ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027Aug 26

Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call TranscriptJun 25

Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate UpdateJun 25

Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026Jun 22

Addex Convenes Annual General Meeting 2026Jun 5

Related Stocks

A
Aptevo Therapeutics Inc.
C
Cadrenal Therapeutics, Inc. Common Stock
M
MBody AI Ltd.
E
Eocene Ltd.
M
Mustang Bio, Inc.
M
Moolec Science S.A.
I
IceCure Medical Ltd
E
Evogene Ltd.

Daily Prices

09.29$2.95+4.98%

09.28$2.81-23.01%

09.25$3.65+5.49%

09.24$3.46+0.29%

09.23$3.45-1.43%

09.22$3.50-0.85%

09.21$3.53+3.82%

09.18$3.40+1.19%

09.17$3.360.00%

09.16$3.36+3.07%

Quarterly Revenue Growth

PriorCurrent

25년 6월25년 9월25년 12월26년 6월

BusinessBiotechnology·addextherapeutics.com↗

“이번 반기 핵심 변화는 Indivior에서 GABAB 양성 알로스테릭 조절제 전 권리를 되찾고 280만 달러를 조달해 현금 운용 기간을 2027”

In the company's words · 2026 2분기 earnings call